Rolando Claure

@runningkidneys.bsky.social

#KidneyDoctor #Researcher Member Executive Committee @kdigo.org Member #SLANH #AKI committee Views do not represent those of my employer #KidneyRunner 🏃🏻‍♂️ #StopAKI

We’re delighted to bring the ISN Primer Course in Renal Pathology to Uruguay, welcoming 73 participants from across Latin America! 🌎 Thanks to our faculty, Hospital de Clínicas & Otsuka for their support.

BildBildBild

🤖 Generative AI holds promise in kidney care—but also risks: bias, hallucinations, automation bias, inequitable access & environmental costs. Safe implementation requires recognizing how these risks interact and may affect patient safety and equity. #AI doi.org/10.1093/ckj/...

Potential risks of generative artificial intelligence in kidney care

Abstract. Generative artificial intelligence (GenAI), particularly large language models, is rapidly emerging as a transformative tool in medicine, includi

doi.org

Pleased to share our new 📑 consensus statement from ADQI XXXV on accelerating evidence-based practices in acute kidney injury. We provide a roadmap to close evidence-to-care gaps through implementation science, equity, and context-adapted solutions. 🔗 doi.org/10.2215/CJN.... #AKI #ADQI

Accelerating Evidence-Based Practices in Acute... : Clinical Journal of the American Society of Nephrology

Scientific evidence regarding AKI and acute kidney care has advanced in recent years. However, a knowledge gap remains on the implementation of these...

doi.org

🤖 can identify 🛌 at ⬆️AKI risk before sCr⬆️ but prediction alone doesn’t prevent AKI. A commentary highlights that AI-triggered early nephrology consultation failed to improve kidney outcomes, underscoring the gap between prediction & prevention. 🔗 doi:10.1001/jamanetworkopen.2026.22565

#AndesCRRT2026 once again demonstrated the power of collaboration. Inspiring discussions, cutting-edge science, and meaningful exchanges among colleagues dedicated to improving outcomes for patients with AKI and critical illness. Proud to be part of this growing Latin American community. 🌎🤝 #AKI

BildBild

Children on CKRT with preserved urine output may benefit from an early liberation trial. In the WE-ROCK study, a day-5 liberation trial was associated with better outcomes (win ratio 2.14), mainly through more ICU- and hospital-free days. 🔗 journals.lww.com/cjasn/pdf/10...

A Hierarchical Endpoint Analysis of the Worldwide... : Clinical Journal of the American Society of Nephrology

Background:Data to guide assessment of readiness for liberation from continuous renal replacement therapy (CRRT) in children are limited, and...

journals.lww.com

Urea may be a cost-effective alternative to tolvaptan for 🏥 SIADH patients. In a retrospective 📑 (n=537) both achieved similar correction of HypoNa (>130 mmol/L) while tolvaptan acted faster but caused more overcorrection & was substantially more 💵 🔗https://doi.org/10.1093/ndt/gfag165

Urea vs. tolvaptan for hospitalized patients with SIADH

AbstractRationale. Hyponatremia is the most common electrolyte disorder found in hospitalized patients and is associated with an increased mortality. Urea

doi.org

A machine learning–guided strategy successfully identified 🏥 patients at ⬆️risk for #AKI, but triggering early nephrology consultation didn’t improve 🫘 function, ⬇️readmissions, or ⬇️mortality better prediction does not guarantee better outcomes. 🔗 jamanetwork.com/journals/jam...

Early Nephrology Consult and Acute Kidney Injury in Hospitalized Patients

This randomized clinical trial assesses whether a structured early nephrology consultation triggered by a machine-learning acute kidney injury (AKI) risk score in patients at high risk for AKI improve...

jamanetwork.com

C5a/C5aR1 may drive the AKI-to-CKD transition. In mice, tubular—not myeloid—C5aR1 promoted inflammation, oxidative stress, apoptosis and fibrosis. C5aR1 deletion or PMX53 enhanced autophagy and mitochondrial function: a therapeutic target. #AKI #CKD 🔗 doi.org/10.1093/ndt/...

C5a/C5aR1 mediates AKI-CKD transition by enhancing autophagy

AbstractBackground. Excessive production of complement C5a detected in acute kidney injury (AKI) and during the development of chronic kidney disease (CKD)

doi.org

Kidney care is no longer just about kidney disease, it’s about #CKM health. There is a evolving role of nephrologists in early screening, prevention, & multidisciplinary care for #CKM syndrome. Breaking silos is essential to improve outcomes. journals.lww.com/cjasn/pdf/10...

Nephrology in the Paradigm of... : Clinical Journal of the American Society of Nephrology

The “Saving Kidneys, Hearts, and Lives” workshop in March 2025, hosted by the American Society of Nephrology, brought together diverse stakeholders...

journals.lww.com

New #NDT study: #Semaglutide did not significantly change measured GFR despite small increases in creatinine and β-trace protein. Combined creatinine+cystatin C eGFR more accurately reflected measured GFR than either marker alone. #Nephrology #CKD 🔗

Effect of Semaglutide on Measured vs Estimated Glomerular Filtration Rate

AbstractBackground and Hypothesis. Semaglutide is a glucagon-like peptide-1 receptor agonist widely used for its glucose-lowering effects in people with ty

doi.org

Does impaired kidney tubular secretion predict AKI during AHF 💔? In a recent 📑 a secretion score based on 11 endogenous tubular secretion markers measured years before hospitalization was not associated with AKI risk during subsequent #AHF admissions. 🔗 journals.lww.com/kidney360/pd...

Association of Markers of Kidney Tubular... : Kidney360

Background:Acute heart failure (heart failure) is a common cause of acute kidney injury (AKI) in hospitalized patients, yet it remains unclear why...

journals.lww.com

In 672 US adults with diabetes and CKD, serum uric acid was not linked to all-cause mortality. However, SUA >9 mg/dL was associated with higher cancer mortality, combined CVD/cancer mortality, and CVD mortality in those without baseline CVD. 🔗 doi.org/10.1038/s415...

Serum uric acid levels and mortality in diabetic patients with chronic kidney disease - Scientific Reports

Scientific Reports - Serum uric acid levels and mortality in diabetic patients with chronic kidney disease

doi.org

The retraction of the ADVOCATE trial marks a pivotal moment for ANCA-associated vasculitis. Scientific integrity is non-negotiable. Yet, patients should not lose access to effective therapies because of research misconduct. Regulators must balance evidence, safety, & patient care

Bild